Literature DB >> 27807689

Real-time three-dimensional echocardiography of left atrial volume and function in patients with severe multi-vessel coronary artery disease.

Lingjie Yang1, Li Ma1, Yanhong Li2, Yuming Mu3, Liyun Liu1.   

Abstract

PURPOSE: To evaluate the changes in left atrial (LA) volume and function in patients with severe multi-vessel coronary artery disease (CAD) by real-time three-dimensional echocardiography (RT-3DE).
METHODS: One hundred and eight subjects were stratified based on coronary angiography (CAG) imaging, comprising 48 patients with severe multi-vessel CAD, 31 patients with severe single-vessel CAD, and 29 controls. RT-3DE was performed in all groups. LA volume parameters were measured. LA ejection fractions (EF) and LA function index (LAFI) were also calculated.
RESULTS: There were no significant differences between the single-vessel CAD group and the control group, while LA passive emptying fraction (LAVpEF) was significantly reduced in the single-vessel CAD group. In the multi-vessel CAD group, LAVpEF and LAFI were lower, while LA presystolic volume (LAVpre) was prominently higher as compared with the other groups, and LA active emptying volume (LAVa) was higher than that in the control group (p < 0.05). Receiver-operating characteristic (ROC) analysis showed that the area under the curve (AUC) of LAVpEF was the largest parameter; the optimal cut-off value, AUC, sensitivity, and specificity were 0.50, 0.864, 93.7, and 72.4 %, respectively.
CONCLUSION: Specifically, conduit function reflects the early changes in LA function, and CAD damage is aggravated with increasing coronary lesions, whereas the booster pump function of severe multi-vessel CAD can increase in compensation. We speculate that LAVpEF may be the most ideal threshold for detecting and differentiating severe CAD patients from controls.

Entities:  

Keywords:  Echocardiography; Left atrial function; Multi-vessel coronary artery disease

Mesh:

Year:  2016        PMID: 27807689     DOI: 10.1007/s10396-016-0754-5

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  16 in total

1.  Evaluation of left atrial function in patients with coronary artery disease by two-dimensional strain and strain rate imaging.

Authors:  Ying-ying Liu; Ming-xing Xie; Jin-feng Xu; Xin-fang Wang; Qing Lv; Xiao-fang Lu; Jing Wang; Lin He; Ling-yun Fang; Jing Zhang
Journal:  Echocardiography       Date:  2011-10-04       Impact factor: 1.724

2.  Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction.

Authors:  Y T Tan; F Wenzelburger; E Lee; P Nightingale; G Heatlie; F Leyva; J E Sanderson
Journal:  Heart       Date:  2010-07       Impact factor: 5.994

3.  Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia.

Authors:  Afshin Farzaneh-Far; Vignendra Ariyarajah; Chetan Shenoy; Jean-Francois Dorval; Matthew Kaminski; Zelmira Curillova; Henry Wu; Kenneth B Brown; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2011-04

4.  Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography.

Authors:  Erlend Aune; Morten Baekkevar; Jo Roislien; Olaf Rodevand; Jan Erik Otterstad
Journal:  Eur J Echocardiogr       Date:  2009-05-12

5.  Proper use of left atrial ejection force as a measure of left atrial mechanical function.

Authors:  Liang Zhong; Ru-San Tan; Dhanjoo Ghista
Journal:  Echocardiography       Date:  2012-08       Impact factor: 1.724

6.  Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation.

Authors:  Norihisa Toh; Hideaki Kanzaki; Satoshi Nakatani; Takahiro Ohara; Jiyoong Kim; Kengo F Kusano; Kazuhiko Hashimura; Tohru Ohe; Hiroshi Ito; Masafumi Kitakaze
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

7.  Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR.

Authors:  Victor Mor-Avi; Chattanong Yodwut; Carly Jenkins; Harald Kühl; Hans-Joachim Nesser; Thomas H Marwick; Andreas Franke; Lynn Weinert; Johannes Niel; Regina Steringer-Mascherbauer; Benjamin H Freed; Lissa Sugeng; Roberto M Lang
Journal:  JACC Cardiovasc Imaging       Date:  2012-08

8.  Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis.

Authors:  Swee Guan Teo; Hilda Yang; Ping Chai; Tiong Cheng Yeo
Journal:  Eur J Echocardiogr       Date:  2009-10-13

Review 9.  Left atrium function in patients with coronary artery disease.

Authors:  Emanuela Facchini; Anna Degiovanni; Paolo N Marino
Journal:  Curr Opin Cardiol       Date:  2014-09       Impact factor: 2.161

10.  Left atrial and right atrial deformation in patients with coronary artery disease: a velocity vector imaging-based study.

Authors:  Ping Yan; Bin Sun; Haiming Shi; Wen Zhu; Qing Zhou; Yuwen Jiang; Hui Zhu; Guoqian Huang
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more
  3 in total

1.  Evaluation of changes in left ventricular structure and function in hypertensive patients with coronary artery disease after PCI using real-time three-dimensional echocardiography.

Authors:  Yanhong Meng; Ling Zong; Ziteng Zhang; Youdong Han; Yanhui Wang
Journal:  Exp Ther Med       Date:  2017-11-22       Impact factor: 2.447

2.  Real-time three-dimensional echocardiography predicts cardiotoxicity induced by postoperative chemotherapy in breast cancer patients.

Authors:  Fang Zhou; Lin Niu; Min Zhao; Wei-Xing Ni; Jian Liu
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

3.  Determinants of the Volumetric Markers of Left Atrial Contraction Function in Coronary Artery Disease: A Cross-sectional Study.

Authors:  Taimoor Etemad; Ali Hosseinsabet; Negar Omidi; Reza Mohseni-Badalabadi
Journal:  J Cardiovasc Imaging       Date:  2022-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.